Giant Cell Myocarditis: Long Term Survival Following Left Ventricular Assist Device Implantation

Giant cell myocarditis (GCM) is a rapidly progressing and frequently fatal disease. Long term survival has been associated previously only with mechanical support and immunosuppression as a bridge to transplant. Here we present two patients with GCM who received advanced heart failure (HF) therapies with mechanical support and who survived with left ventricular assist device (LVAD) implantation.